US · Healthcare · Medical Devices
EPS came in at -0.27 against a street estimate of -0.26 — a miss of 3.8%.
Analysts rate Rapid Micro Biosystems Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $5.75.
| Fund | Stake |
|---|---|
| Bain Capital Life Sciences Investors, LLC | 16.82% |
| Armistice Capital, LLC | 6.63% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 3.68% |
| Vanguard Capital Management, LLC | 1.96% |
| Evernest Financial Advisors LLC | 1.01% |
| Advent International LP | 0.76% |
| Essex Investment Management Company, LLC | 0.72% |
| Millennium Management LLC | 0.47% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rapid Micro Biosystems Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.